Skip to main content
Skip to content
1 duplicate copy in the archive
Case File
d-16299House Oversight

Goldman Sachs Options and OTC Derivatives Risk Disclosure

Other

The document is a standard risk disclaimer for options and OTC derivatives with no specific names, transactions, dates, or allegations linking powerful actors to misconduct. It offers no actionable in Describes risks of buying and selling options, including total loss of premium. Outlines OTC derivative risks such as liquidity, counterparty credit, and pricing concerns. Mentions Goldman Sachs & Co

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #025696
Pages
2
Persons
2
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.